Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

Depolarizing Blockers: Mechanism of Action

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Parenteral Anesthetics: Overview

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An amygdala-cortical circuit for encoding generalized fear memories.

Molecular psychiatry·2025

Same author

An amygdala-cortical circuit for encoding generalized fear memories.

bioRxiv : the preprint server for biology·2025

Same author

Synaptic acetylcholine induces sharp wave ripples in the basolateral amygdala through nicotinic receptors.

bioRxiv : the preprint server for biology·2024

Same author

Acetylcholine Engages Distinct Amygdala Microcircuits to Gate Internal Theta Rhythm.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2024

Same author

Differential Regulation of Prelimbic and Thalamic Transmission to the Basolateral Amygdala by Acetylcholine Receptors.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2022

Same author

Reduced expression of perineuronal nets in the normotopic somatosensory cortex of the tish rat.

Brain research·2022

Search research articles

Related Experiment Video

Updated: May 8, 2026

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Stiripentol in refractory status epilepticus.

Denise K Grosenbaugh¹, David D Mott

¹Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC 29209, U.S.A.

|September 5, 2013

Summary

Stiripentol (STP) effectively stops seizures in a rodent model of status epilepticus (SE), even when benzodiazepine-resistant. STP works by targeting a different site on GABA receptors, showing promise for treating difficult SE cases, especially in children.

Keywords:

Anticonvulsant Benzodiazepine Dentate gyrus GABAergic inhibition IPSC Seizure

More Related Videos

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Related Experiment Videos

Last Updated: May 8, 2026

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Area of Science:

Neuroscience
Pharmacology
Epilepsy Research

Background:

Status epilepticus (SE) is a medical emergency characterized by prolonged seizures.
Benzodiazepines (BZDs) are first-line SE treatment but often face rapid pharmacoresistance.
This resistance is linked to BZD-sensitive GABA receptor internalization during SE.

Purpose of the Study:

To investigate the efficacy of Stiripentol (STP) in a rodent model of SE.
To determine if STP is effective against BZD-resistant SE.
To explore the age-dependency of STP's anticonvulsant effects.

Main Methods:

Utilized a rodent model of status epilepticus.
Administered Stiripentol (STP) to assess seizure termination and efficacy in established SE.
Performed whole-cell recordings in hippocampal slices to analyze STP's effect on GABAergic currents.
Compared STP's efficacy in juvenile versus adult animals.

Main Results:

STP effectively terminated behavioral seizures in the rodent SE model.
STP remained effective in established SE, where seizures were BZD-resistant.
STP potentiates GABAergic currents via a distinct binding site, unaffected by BZD resistance mechanisms.
STP demonstrated greater potency in juvenile animals compared to adults.

Conclusions:

STP is effective in terminating BZD-resistant status epilepticus.
STP's unique mechanism of action offers an alternative for SE treatment.
STP may be particularly beneficial for treating SE in children, where it is most prevalent.